Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUDIOWOLF sodium valproate study in Wolfram syndrome
2020-004594-43Phase 2Active
- Sponsor
- CECS
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Sodium valproate + valproic acid and valproic acid in Wolfram syndrome, sponsored by CECS. Primary endpoints: Preservation of auditory function and Audiometric assessments. Started Mar 2021; status: active.
02
Drugs
Sodium valproate + valproic acidvalproic acid
03
Conditions
Wolfram syndrome
Beyond the preview
Go deeper on 2020-004594-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004594-43.